Investors have big expections for generative AI startups

The company then spent the next decade, and billions of dollars, trying to use Watson's artificial intelligence capabilities to solve a broad set of healthcare challenges, from helping doctors diagnose diseases based on symptoms to recommending clinical trials. In January, IBM announced it was selling Watson for parts to PE firm Francisco Partners. AI technologies have come a long way since that game show triumph. Some AI, such as those recommending ads on Google or detecting cancer on medical scans, have become part of everyday life. While improvements for these types of AI have been mostly incremental, over the last year machines suddenly became good at generating images and writing text.